Karuna Therapeutics Inc
Change company Symbol lookup
Select an option...
KRTX Karuna Therapeutics Inc
GWPAX American Funds Growth Portfolio Class A
LIXTW Lixte Biotechnology Holdings Equity Warrants Exp 1st Jan 2025 *W EXP 01/01/2025
ZIONP Zions Bancorporation NA
BLK BlackRock Inc
GTEH Gentech Holdings Inc
$SPCOMBULD S&P 1500 Building Products(Sub Ind)
KELYA Kelly Services Inc
SONY Sony Group Corp
BVNRY Bavarian Nordic A/S
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Karuna Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on creating and delivering transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate, KarXT, is an oral modulator of muscarinic receptors that are located both in the central nervous system (CNS) and various peripheral tissues. It is initially developing KarXT, for the treatment of acute psychosis in patients with schizophrenia. The Company is for the treatment of psychosis in Alzheimer's disease (AD), which is the prevalent subtype of dementia-related psychosis (DRP). KarXT is a combination of xanomeline and trospium. It is advancing a pipeline of therapeutic programs to address the positive, negative and cognitive symptoms associated with schizophrenia and dementia-related psychosis (DRP). Its muscarinic receptors serve a number of physiological roles, including in cognitive, behavioral, sensory, motor and autonomic processes.

Closing Price
$104.53
Day's Change
0.46 (0.44%)
Bid
--
Ask
--
B/A Size
--
Day's High
105.82
Day's Low
99.82
Volume
(Light)
Volume:
173,125

10-day average volume:
310,117
173,125

Unable to locate that news article. Back to news results

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.